CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
+4.9%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$1.64B
AUM Growth
+$1.64B
(-3.1%)
Cap. Flow
-$195M
Cap. Flow
% of AUM
-11.89%
Top 10 Holdings %
Top 10 Hldgs %
64.86%
Holding
40
New
9
Increased
6
Reduced
9
Closed
7
Top Buys
| 1 |
Tenet Healthcare
THC
|
$77.4M |
| 2 |
AMAG
AMAG Pharmaceuticals, Inc.
AMAG
|
$31.3M |
| 3 |
Biogen
BIIB
|
$27.1M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$24.3M |
| 5 |
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
|
$23.2M |
Top Sells
| 1 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$64.5M |
| 2 |
LivaNova
LIVN
|
$58.8M |
| 3 |
Perrigo
PRGO
|
$53.7M |
| 4 |
CSII
Cardiovascular Systems, Inc.
CSII
|
$49.5M |
| 5 |
Abbott
ABT
|
$44.4M |
Sector Composition
| 1 | Healthcare | 86.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Teva Pharmaceuticals
TEVA
$21.1B
| $175M | 8.52% | 5,266,450 +50,000 | +1% | +$1.66M |
|
2
Viatris
VTRS
$12.3B
| $165M | 8.02% | 4,245,889 +100,000 | +2% | +$3.88M |
|
3
Gilead Sciences
GILD
$140B
| $142M | 6.89% | 2,000,000 +100,000 | +5% | +$7.08M |
|
4
Nektar Therapeutics
NKTR
$568M
| $105M | 5.09% | 5,350,000 -50,000 | -0.9% | -$978K |
|
|
AGN
5
DELISTED
Allergan plc
AGN
| $85.1M | 4.14% | 350,000 -85,750 | -20% | -$20.8M |
|
|
GHDX
6
DELISTED
Genomic Health, Inc.
GHDX
| $80M | 3.9% | 2,458,100 | – | – |
|
7
Brookdale Senior Living
BKD
$1.83B
| $79.4M | 3.87% | 5,400,000 -100,000 | -2% | -$1.47M |
|
8
Myriad Genetics
MYGN
$593M
| $77.5M | 3.77% | 3,000,000 -1,325,000 | -31% | -$34.2M |
|
|
9
Tenet Healthcare
THC
$16.3B
| $77.4M | 3.77% | +4,000,000 | New | +$77.4M |
|
10
Select Medical
SEM
$1.61B
| $76.8M | 3.74% | 5,000,000 | – | – |
|
|
BIVV
11
DELISTED
Bioverativ Inc. Common Stock
BIVV
| $70.7M | 3.44% | 1,174,300 +74,300 | +7% | +$4.47M |
|
12
Orthofix Medical
OFIX
$592M
| $69.7M | 3.39% | 1,500,000 | – | – |
|
13
Vertex Pharmaceuticals
VRTX
$100B
| $45.1M | 2.2% | 350,000 -300,000 | -46% | -$38.7M |
|
14
Sarepta Therapeutics
SRPT
$1.78B
| $43.8M | 2.13% | 1,300,000 -50,000 | -4% | -$1.69M |
|
|
ENDP
15
DELISTED
Endo International plc
ENDP
| $39.9M | 1.94% | 3,574,000 -1,478,000 | -29% | -$16.5M |
|
|
ELGX
16
DELISTED
Endologix Inc
ELGX
| $36.5M | 1.77% | 7,500,000 +1,500,000 | +25% | +$7.29M |
|
|
AMAG
17
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $31.3M | 1.52% | +1,700,000 | New | +$31.3M |
|
18
Option Care Health
OPCH
$4.65B
| $27.6M | 1.35% | 10,180,000 | – | – |
|
|
19
Biogen
BIIB
$19.4B
| $27.1M | 1.32% | +100,000 | New | +$27.1M |
|
|
ELOS
20
DELISTED
Syneron Medical Ltd
ELOS
| $25.7M | 1.25% | 2,347,593 | – | – |
|
|
ALXN
21
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $24.3M | 1.18% | +200,000 | New | +$24.3M |
|
|
SIOX
22
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $23.2M | 1.13% | +1,000,000 | New | +$23.2M |
|
|
NVTA
23
DELISTED
Invitae Corporation
NVTA
| $22.9M | 1.12% | 2,398,123 | – | – |
|
|
EVHC
24
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $21.9M | 1.07% | +350,000 | New | +$21.9M |
|
|
AVXS
25
DELISTED
AveXis, Inc. Common Stock
AVXS
| $17.3M | 0.84% | +210,000 | New | +$17.3M |
|